DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • User Profile
  • /
  • Watchlists
  • /
  • The Permission Moat
Public Watchlist
DA
darius_john
darius_john

The Permission Moat

Twenty US companies whose most valuable asset isn't a product, a patent or a brand — it's a permission. A zoning approval, an operating licence, a legacy registration, a certification held by their customer's regulator. In every case a competitor with unlimited capital cannot obtain the same permission today, at any price. What makes these different from the obvious regulated monopolies is that the regulator limits their supply without capping their price.

2.6k Views

Watching

20

  • 1M
  • 3M
  • 1Y
FV & Narrative
Valuation
Growth
Analyst Target

WST

West Pharmaceutical Services

US$365.009.6% undervalued intrinsic discount
8.1%7D
12.8%3M
A
AnalystConsensusTarget
US$403.93author fair value
28 Julauthor updated this narrative

Analysts Raise Target for West Pharmaceutical Services Amid Strong Outlook and Upgraded Guidance

RGEN

Repligen

US$174.736.9% undervalued intrinsic discount
3.7%7D
30.8%3M
A
AnalystConsensusTarget
US$187.7author fair value
04 Sepauthor updated this narrative

Recovery In Industry Demand And Market Stability Will Drive Renewed Momentum

BR

Broadridge Financial Solutions

US$170.2533.2% undervalued intrinsic discount
1.0%7D
21.9%3M
A
AnalystHighTarget
US$255author fair value
08 Mayauthor updated this narrative

Tokenization And AI Adoption Will Cement A Leading Role In Future Financial Infrastructure

CLH

Clean Harbors

US$318.2011.3% undervalued intrinsic discount
0.3%7D
10.8%3M
A
AnalystConsensusTarget
US$358.93author fair value
31 Julauthor updated this narrative

CLH: Record Cash Flows And PFAS Destruction Will Drive Strong Returns

LNTH

Lantheus Holdings

US$100.3222.2% undervalued intrinsic discount
-0.6%7D
-4.5%3M
A
AnalystHighTarget
US$129author fair value
20 Julauthor updated this narrative

Pylarify And Theranostics Expansion Will Capture Global Aging Demand

SCI

Service Corporation International

US$81.2017.7% undervalued intrinsic discount
0.3%7D
11.9%3M
A
AnalystConsensusTarget
US$98.67author fair value
01 Augauthor updated this narrative

Share Repurchase Momentum And Margin Gains Will Shape Future Performance

AVD

American Vanguard

US$2.2681.2% undervalued intrinsic discount
-0.9%7D
-12.7%3M
A
AnalystConsensusTarget
US$12author fair value
09 Mayauthor updated this narrative

Green Solutions And Global Expansion Will Shape Future Markets

DAR

Darling Ingredients

US$66.5426.1% undervalued intrinsic discount
-0.8%7D
23.7%3M
A
AnalystHighTarget
US$90author fair value
24 Augauthor updated this narrative

Decarbonization And Upcycling Will Empower Renewable Biofuel Markets

CWST

Casella Waste Systems

US$90.3419.3% undervalued intrinsic discount
-1.9%7D
4.9%3M
A
AnalystConsensusTarget
US$112author fair value
15 Junauthor updated this narrative

CWST: Inorganic Expansion Will Drive Long-Term Compounding Despite Short-Term Challenges

CRL

Charles River Laboratories International

US$272.8813.0% undervalued intrinsic discount
-2.8%7D
49.7%3M
A
AnimalDoctorKwon
US$313.61author fair value
12 Marauthor updated this narrative

A Company Preparing for the Future: Charles River Laboratories

DFIN

Donnelley Financial Solutions

US$47.8624.0% undervalued intrinsic discount
-3.9%7D
21.4%3M
A
AnalystConsensusTarget
US$63author fair value
16 Junauthor updated this narrative

DFIN: Platform Advancements And Margin Expansion Will Drive Outperformance

OLN

Olin

US$17.1438.1% undervalued intrinsic discount
-4.2%7D
-25.5%3M
A
AnalystHighTarget
US$27.67author fair value
26 Augauthor updated this narrative

Global Urbanization And Electrification Will Expand Specialty Chemicals Markets

CPRT

Copart

US$31.0436.7% undervalued intrinsic discount
-4.8%7D
5.1%3M
W
WealthAP
US$49author fair value
15 Julauthor updated this narrative

Copart’s Share Price Fell. Its Moat Did Not.

ASLE

AerSale

US$5.4032.5% undervalued intrinsic discount
-5.1%7D
-16.9%3M
A
AnalystHighTarget
US$8author fair value
10 Augauthor updated this narrative

Rising Global Air Travel Will Spark Aircraft Modernization Surge

PAHC

Phibro Animal Health

US$35.9421.2% undervalued intrinsic discount
-6.0%7D
12.8%3M
A
AnalystConsensusTarget
US$45.6author fair value
04 Junauthor updated this narrative

Feed Additives And Vaccines Will Shape Global Market Amid Headwinds

MIR

Mirion Technologies

US$15.6736.8% undervalued intrinsic discount
-7.4%7D
-11.2%3M
A
AnalystConsensusTarget
US$24.8author fair value
30 Julauthor updated this narrative

MIR: Expect Opportunities As New Partnerships And Index Inclusions Shape Outlook

CBOE

Cboe Global Markets

US$270.8313.3% undervalued intrinsic discount
-7.7%7D
6.3%3M
A
AnalystConsensusTarget
US$312.36author fair value
10 Julauthor updated this narrative

CBOE: New Fee Dynamics And Earnings Guidance Will Shape Near-Term Outlook

BWXT

BWX Technologies

US$146.7033.3% undervalued intrinsic discount
-8.5%7D
-27.8%3M
C
US$220author fair value
29 Sepauthor updated this narrative

M&A Activity, Industry Diversification & A Defense Contract Monopoly Will Push BWXT For Healthy Long-Term Growth

CEG

Constellation Energy

US$259.8925.7% undervalued intrinsic discount
-13.1%7D
-2.7%3M
A
andrei9868
US$350author fair value
16 Augauthor updated this narrative

Constellation Energy ($CEG): The Nuclear Scarcity Play Powering the AI Demand Boom

LEU

Centrus Energy

US$142.1225.2% undervalued intrinsic discount
-23.4%7D
-16.6%3M
C
CentryResearch
US$190author fair value
17 Julauthor updated this narrative

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Watching

20

  • 1M
  • 3M
  • 1Y
FV & Narrative
Valuation
Growth
Analyst Target

WST

West Pharmaceutical Services

8.1%7D
12.8%3M

US$365.00

9.6% undervalued intrinsic discount
A
AnalystConsensusTarget
US$403.93author fair value
28 Julauthor updated this narrative

Analysts Raise Target for West Pharmaceutical Services Amid Strong Outlook and Upgraded Guidance

PE 45.5x
E 11.1%
US$405.38

RGEN

Repligen

3.7%7D
30.8%3M

US$174.73

6.9% undervalued intrinsic discount
A
AnalystConsensusTarget
US$187.7author fair value
04 Sepauthor updated this narrative

Recovery In Industry Demand And Market Stability Will Drive Renewed Momentum

PS 12.6x
E 36.8%
US$189.48

BR

Broadridge Financial Solutions

1.0%7D
21.9%3M

US$170.25

33.2% undervalued intrinsic discount
A
AnalystHighTarget
US$255author fair value
08 Mayauthor updated this narrative

Tokenization And AI Adoption Will Cement A Leading Role In Future Financial Infrastructure

PE 17.3x
E 5.9%
US$213.38

CLH

Clean Harbors

0.3%7D
10.8%3M

US$318.20

11.3% undervalued intrinsic discount
A
AnalystConsensusTarget
US$358.93author fair value
31 Julauthor updated this narrative

CLH: Record Cash Flows And PFAS Destruction Will Drive Strong Returns

PE 38.3x
E 9.3%
US$359.93

LNTH

Lantheus Holdings

-0.6%7D
-4.5%3M

US$100.32

22.2% undervalued intrinsic discount
A
AnalystHighTarget
US$129author fair value
20 Julauthor updated this narrative

Pylarify And Theranostics Expansion Will Capture Global Aging Demand

PE 23.8x
E 26.0%
US$107.74

SCI

Service Corporation International

0.3%7D
11.9%3M

US$81.20

17.7% undervalued intrinsic discount
A
AnalystConsensusTarget
US$98.67author fair value
01 Augauthor updated this narrative

Share Repurchase Momentum And Margin Gains Will Shape Future Performance

PE 20.6x
E 8.1%
US$100.33

AVD

American Vanguard

-0.9%7D
-12.7%3M

US$2.26

81.2% undervalued intrinsic discount
A
AnalystConsensusTarget
US$12author fair value
09 Mayauthor updated this narrative

Green Solutions And Global Expansion Will Shape Future Markets

PS 0.1x
S n/a
n/a

DAR

Darling Ingredients

-0.8%7D
23.7%3M

US$66.54

26.1% undervalued intrinsic discount
A
AnalystHighTarget
US$90author fair value
24 Augauthor updated this narrative

Decarbonization And Upcycling Will Empower Renewable Biofuel Markets

PE 17.6x
E 13.8%
US$80.75

CWST

Casella Waste Systems

-1.9%7D
4.9%3M

US$90.34

19.3% undervalued intrinsic discount
A
AnalystConsensusTarget
US$112author fair value
15 Junauthor updated this narrative

CWST: Inorganic Expansion Will Drive Long-Term Compounding Despite Short-Term Challenges

PS 2.9x
E 88.2%
US$111.80

CRL

Charles River Laboratories International

-2.8%7D
49.7%3M

US$272.88

13.0% undervalued intrinsic discount
A
AnimalDoctorKwon
US$313.61author fair value
12 Marauthor updated this narrative

A Company Preparing for the Future: Charles River Laboratories

PS 3.3x
E 43.9%
US$282.43

DFIN

Donnelley Financial Solutions

-3.9%7D
21.4%3M

US$47.86

24.0% undervalued intrinsic discount
A
AnalystConsensusTarget
US$63author fair value
16 Junauthor updated this narrative

DFIN: Platform Advancements And Margin Expansion Will Drive Outperformance

PE 33.4x
E 35.1%
US$64.00

OLN

Olin

-4.2%7D
-25.5%3M

US$17.14

38.1% undervalued intrinsic discount
A
AnalystHighTarget
US$27.67author fair value
26 Augauthor updated this narrative

Global Urbanization And Electrification Will Expand Specialty Chemicals Markets

PS 0.3x
E 70.6%
US$21.73

CPRT

Copart

-4.8%7D
5.1%3M

US$31.04

36.7% undervalued intrinsic discount
W
WealthAP
US$49author fair value
15 Julauthor updated this narrative

Copart’s Share Price Fell. Its Moat Did Not.

PE 19.4x
E 7.3%
US$39.70

ASLE

AerSale

-5.1%7D
-16.9%3M

US$5.40

32.5% undervalued intrinsic discount
A
AnalystHighTarget
US$8author fair value
10 Augauthor updated this narrative

Rising Global Air Travel Will Spark Aircraft Modernization Surge

PS 0.8x
E 114.2%
US$7.25

PAHC

Phibro Animal Health

-6.0%7D
12.8%3M

US$35.94

21.2% undervalued intrinsic discount
A
AnalystConsensusTarget
US$45.6author fair value
04 Junauthor updated this narrative

Feed Additives And Vaccines Will Shape Global Market Amid Headwinds

PE 14.6x
E 14.6%
US$44.00

MIR

Mirion Technologies

-7.4%7D
-11.2%3M

US$15.67

36.8% undervalued intrinsic discount
A
AnalystConsensusTarget
US$24.8author fair value
30 Julauthor updated this narrative

MIR: Expect Opportunities As New Partnerships And Index Inclusions Shape Outlook

PS 3.7x
E 53.8%
US$24.27

CBOE

Cboe Global Markets

-7.7%7D
6.3%3M

US$270.83

13.3% undervalued intrinsic discount
A
AnalystConsensusTarget
US$312.36author fair value
10 Julauthor updated this narrative

CBOE: New Fee Dynamics And Earnings Guidance Will Shape Near-Term Outlook

PE 21x
E 4.1%
US$315.64

BWXT

BWX Technologies

-8.5%7D
-27.8%3M

US$146.70

33.3% undervalued intrinsic discount
C
US$220author fair value
29 Sepauthor updated this narrative

M&A Activity, Industry Diversification & A Defense Contract Monopoly Will Push BWXT For Healthy Long-Term Growth

PE 37.8x
E 11.9%
US$226.58

CEG

Constellation Energy

-13.1%7D
-2.7%3M

US$259.89

25.7% undervalued intrinsic discount
A
andrei9868
US$350author fair value
16 Augauthor updated this narrative

Constellation Energy ($CEG): The Nuclear Scarcity Play Powering the AI Demand Boom

PE 26.6x
E 17.0%
US$348.30

LEU

Centrus Energy

-23.4%7D
-16.6%3M

US$142.12

25.2% undervalued intrinsic discount
C
CentryResearch
US$190author fair value
17 Julauthor updated this narrative

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

PE 59.9x
E 5.7%
US$247.40

Comments

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide